Epidemiology and pathophysiology

Ji, Prof. L., Peking, China
Diabetes in Asia: Strategies for CVD prevention
Saadi, MD H., Abu Dhabi, United Arab Emirates
Type 2 diabetes: the Middle Eastern perspective
Tuomilehto, Prof. J., Helsinki, Finland
Genome-wide association data and CV risk
Roden, Prof. M., Duesseldorf, Germany
Mitochondrial dysfunction and type 2 diabetes: pathways for cardiovascular complications
Ji, Prof. L., Peking, China
Diabetes and CVD in China
Raposo, Prof. J. F., Lissabon, Portugal
The diabetes pandemic: a Portuguese perspective
Ceriello, Prof. A., Barcelona, Spain
Postprandial hyperglycaemia as a driving force in diabetes and CVD(Archiv)
18-Oct-09
Matthews, Prof. D., University of Oxford, Oxford, United Kingdom
Natural History of Type 2 Diabetes(Archiv)
07-Sep-08
Zimmet, Prof. P., Mellbourne, Australia
The Metabolic Syndrome: The New Global IDF Criteria(Archiv)
22-Sep-06
Standl, Prof. E., Munich, Germany
Metabolic Syndrome – Indicator of a Vascular Catastrophy(Archiv)
22-Sep-06
Hirsch, Dr. I. B., Seattle, United States
Glycemic Variability and Intensive Insulin Therapy(Archiv)
12-Sep-06
Beisswenger, Dr. P. J., New Hampshire, United States
Postprandial Metabolic Effects: Clinical Implications(Archiv)
12-Sep-06
Froguel, Prof. A., London, United Kingdom
The RAS and the pathogenesis of diabetes(Archiv)
11-Sep-05
Holman, Prof. R., Oxford, United Kingdom
Addressing the Diabetes Epidemic: Lessons From the NAVIGATOR Trial(Archiv)
13-Apr-05
Hsu, Dr. W. C., Boston, United States
Diabetes epidemic in asian descent - a prespective from the asian american countries(Archiv)
05-Sep-04
Ceriello, Prof. A., Barcelona, Spain
The metabolic events in the postprandial period(Archiv)
05-Sep-04
Gautier, Prof. J. F., Paris, France
Etiology of beta cell dysfunction(Archiv)
05-Sep-04